« Previous
Next »
Gastroenterology
Volume 141, Issue 6
, Pages
1963-1967
, December 2011
Interferon-Free Treatment Regimens for Hepatitis C: Are We There Yet?
-
HCV replication cycle, the potential drug targets and a list of DAAs in phase II/III clinical trials (data available at: www.clinicaltrials.gov). The steps of HCV replication cycle include cell bindin
HCV replication cycle, the potential drug targets and a list of DAAs in phase II/III clinical trials (data available at: www.clinicaltrials.gov). The steps of HCV replication cycle include cell binding and entry into the hepatocyte, followed by uncoating of HCV and transfer of HCV RNA into endoplasmic reticulum where polyprotein translation and protein processing occurs. This is followed by viral transcription, assembly and export. (Adapted from Lindenbach and Rice4 and Schlutter5). IRES, internal ribosome entry site; LDL, low density lipoprotein; NKT, natural killer T-cell; NS, nonstructural; VLDL, very low density lipoprotein.
Conflict of interest Dr Lok receives research grant support from Bristol-Myers Squibb, GlaxoSmithKline, Gilead, Roche, and Merck, and has served on the advisory/Data and Safety Monitoring Panel for Abbott, Bristol-Myers Squibb, GlaxoSmithKline, Gilead, and Roche.
Funding Dr Sharma is supported by National Institutes of Health (NIH) grant KO8 DK-088946.
PII: S0016-5085(11)01463-6
doi: 10.1053/j.gastro.2011.10.020
© 2011 AGA Institute. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Gastroenterology
Volume 141, Issue 6
, Pages
1963-1967
, December 2011

